Atlas Trials

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

Clinical trial NCT02506777 · UNKNOWN

Trial details

NCT number
NCT02506777
Sponsor
N.N. Petrov National Medical Research Center of Oncology
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-07-01
Primary completion
2020-08-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.